
Treatment for over 50% of breast cancer survivors extends beyond surgery, radiation, and chemotherapy. Doctors recommend medication to inhibit sex hormones, reducing tumor risk by up to 50% in hormone receptor-positive (HR+) breast cancer patients. However, 40% discontinue meds prematurely, and 33% don't follow prescriptions properly. New research from CU Boulder reveals strategies to improve adherence, with interventions increasing compliance by 1.5 times. Cost-cutting policies, mobile apps, and behavioral counseling showed promise. Educating on side effects alone proved ineffective. Innovative approaches like motivation-focused stickers on pill boxes can make a difference. Addressing depression's role is the next focus.
Like
Save
Share